Sarepta Therapeutics Inc (SRPT)
114.04
+3.54
(+3.20%)
USD |
NASDAQ |
Nov 22, 11:44
Sarepta Therapeutics Total Liabilities (Quarterly): 2.379B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.379B |
| June 30, 2024 | 2.347B |
| March 31, 2024 | 2.263B |
| December 31, 2023 | 2.405B |
| September 30, 2023 | 2.345B |
| June 30, 2023 | 2.384B |
| March 31, 2023 | 2.347B |
| December 31, 2022 | 2.743B |
| September 30, 2022 | 2.725B |
| June 30, 2022 | 2.270B |
| March 31, 2022 | 2.199B |
| December 31, 2021 | 2.220B |
| September 30, 2021 | 2.193B |
| June 30, 2021 | 2.274B |
| March 31, 2021 | 2.230B |
| December 31, 2020 | 2.223B |
| September 30, 2020 | 1.889B |
| June 30, 2020 | 1.840B |
| March 31, 2020 | 1.803B |
| December 31, 2019 | 1.005B |
| September 30, 2019 | 707.27M |
| June 30, 2019 | 648.59M |
| March 31, 2019 | 615.33M |
| December 31, 2018 | 609.80M |
| September 30, 2018 | 543.06M |
| Date | Value |
|---|---|
| June 30, 2018 | 548.11M |
| March 31, 2018 | 523.52M |
| December 31, 2017 | 518.75M |
| September 30, 2017 | 103.12M |
| June 30, 2017 | 72.37M |
| March 31, 2017 | 82.39M |
| December 31, 2016 | 87.41M |
| September 30, 2016 | 78.69M |
| June 30, 2016 | 82.61M |
| March 31, 2016 | 74.40M |
| December 31, 2015 | 83.44M |
| September 30, 2015 | 61.52M |
| June 30, 2015 | 66.33M |
| March 31, 2015 | 41.95M |
| December 31, 2014 | 47.38M |
| September 30, 2014 | 32.85M |
| June 30, 2014 | 37.39M |
| March 31, 2014 | 46.43M |
| December 31, 2013 | 44.38M |
| September 30, 2013 | 57.50M |
| June 30, 2013 | 94.81M |
| March 31, 2013 | 106.06M |
| December 31, 2012 | 81.31M |
| September 30, 2012 | 57.65M |
| June 30, 2012 | 19.60M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.005B
Minimum
Dec 2019
2.743B
Maximum
Dec 2022
2.204B
Average
2.267B
Median
Total Liabilities (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 111.07M |
| Madrigal Pharmaceuticals Inc | 296.11M |
| Vertex Pharmaceuticals Inc | 6.609B |
| Viking Therapeutics Inc | 26.44M |
| Regenxbio Inc | 217.70M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.600B |
| Shareholders Equity (Quarterly) | 1.221B |
| Debt to Equity Ratio | 1.005 |
| Current Ratio | 3.839 |
| Net Debt Paydown Yield | 0.01% |